Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Amobarbital
Drug ID BADD_D00126
Description A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
Indications and Usage
Marketing Status Not Available
ATC Code N05CA02
DrugBank ID DB01351
KEGG ID D00555
MeSH ID D000654
PubChem ID 2164
TTD Drug ID D0R6BR
NDC Product Code Not Available
Synonyms Amobarbital | Amylobarbitone | Placidel | Amobarbital Sodium | Sodium, Amobarbital | Sodium Amobarbital | Amobarbital, Sodium | Amsal | Amylbarb sodium | Amylobeta | Amytal | Amytal Sodium | Sodium Amytal | Barbamyl | Eunoctal | Isoamitil Sedante | Isonal | Neur-Amyl | Novamobarb | Pentymal | Transital
Chemical Information
Molecular Formula C11H18N2O3
CAS Registry Number 57-43-2
SMILES CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Agitation19.06.02.001; 17.02.05.012--
Anaemia megaloblastic14.12.01.003; 01.03.02.003--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anxiety19.06.02.002--
Apnoea22.02.01.001--
Ataxia17.02.02.001; 08.01.02.004--
Atelectasis22.01.02.001--
Body temperature increased13.15.01.001--Not Available
Bradycardia02.03.02.002--Not Available
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Depressed level of consciousness17.02.04.002--
Dermatitis23.03.04.002--Not Available
Dermatitis exfoliative23.03.07.001; 10.01.01.004--
Dizziness17.02.05.003; 02.01.02.004; 24.06.02.007--
Feeling abnormal08.01.09.014--Not Available
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatocellular injury09.01.07.008--Not Available
Hyperkinesia17.01.02.008--Not Available
Hypersensitivity10.01.03.003--
Hypotension24.06.03.002--
Hypoventilation22.02.01.007--Not Available
Hypoxia22.02.02.003--
Injection site reaction12.07.03.015; 08.02.03.014--
Loss of consciousness17.02.04.004--Not Available
Mental disability26.01.01.001--Not Available
Nausea07.01.07.001--
Nervousness19.06.02.003--Not Available
Nightmare19.02.03.003--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages